secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gain Therapeutics, Inc. (GANX)
CIK:        0001819411
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001104659-23-074369
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Gain Therapeutics stockholders elect all 8 director nominees, ratify EY as auditor
--------------------------------------------------------------------------------

- All 8 director nominees elected; highest votes for Gwen Melincoff (3,719,922 for), lowest for Hans Peter Hasler (3,491,745 for).
- Ernst & Young AG ratified as independent auditor for FY2023 with 7,927,104 votes for, 4,642 against, 11,513 abstentions.
- Annual meeting held June 23, 2023; quorum present and all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819411/000110465923074369/0001104659-23-074369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819411/000110465923074369/tm2319589d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-074369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer